D

Devyser Diagnostics AB
STO:DVYSR

Watchlist Manager
Devyser Diagnostics AB
STO:DVYSR
Watchlist
Price: 120 SEK 8.11% Market Closed
Market Cap: 2B SEK

Wall Street
Price Targets

DVYSR Price Targets Summary
Devyser Diagnostics AB

Wall Street analysts forecast DVYSR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DVYSR is 169.32 SEK with a low forecast of 163.62 SEK and a high forecast of 178.5 SEK.

Lowest
Price Target
163.62 SEK
36% Upside
Average
Price Target
169.32 SEK
41% Upside
Highest
Price Target
178.5 SEK
49% Upside
Devyser Diagnostics AB Competitors:
Price Targets
QTTB
Homology Medicines Inc
291% Upside
600201
Jinyu Bio-Technology Co Ltd
42% Downside
GNFT
Genfit SA
74% Upside
BNTX
BioNTech SE
47% Upside
688177
Bio-Thera Solutions Ltd
55% Upside
ACLX
Arcellx Inc
59% Upside
LGND
Ligand Pharmaceuticals Inc
28% Upside
ABBV
Abbvie Inc
11% Upside

Revenue
Forecast

Revenue Estimate
Devyser Diagnostics AB

For the last 5 years the compound annual growth rate for Devyser Diagnostics AB's revenue is 28%. The projected CAGR for the next 4 years is 36%.

28%
Past Growth
36%
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Devyser Diagnostics AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
27%
Average Beat

Net Income
Forecast

Net Income Estimate
Devyser Diagnostics AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DVYSR's stock price target?
Price Target
169.32 SEK

According to Wall Street analysts, the average 1-year price target for DVYSR is 169.32 SEK with a low forecast of 163.62 SEK and a high forecast of 178.5 SEK.

What is Devyser Diagnostics AB's Revenue forecast?
Projected CAGR
36%

For the last 5 years the compound annual growth rate for Devyser Diagnostics AB's revenue is 28%. The projected CAGR for the next 4 years is 36%.

Back to Top